Ira N. Kalfus

Ira N. Kalfus

Chief Tech/Sci/R&D Officer chez REDHILL BIOPHARMA LTD.

63 ans
Health Services
Health Technology
Finance

Profil

Ira N.
Kalfus
is currently working as the Medical Director at RedHill Biopharma Ltd.
He is also serving as the Chief Medical Officer at LifeSci Venture Partners and Attune Pharmaceuticals, Inc. In the past, Dr. Kalfus held positions such as Chairman-Performance Improvement at Long Island Jewish Medical Center, Medical Director at US Healthcare, Inc. and Aetna, Inc., Director at Anpath Group, Inc., Chief Medical Officer at Thar Pharmaceuticals, Inc., and Vice President-Medical Affairs at Lev Pharmaceuticals, Inc. Dr. Kalfus completed his undergraduate degree at The Trustees of Columbia University in The City of New York and obtained his doctorate degree from Albert Einstein College of Medicine, Inc.

Postes actifs de Ira N. Kalfus

SociétésPosteDébut
REDHILL BIOPHARMA LTD. Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal 01/06/2019
Chief Tech/Sci/R&D Officer 01/06/2017
Tous les postes actifs de Ira N. Kalfus

Anciens postes connus de Ira N. Kalfus

SociétésPosteFin
AETNA Chief Tech/Sci/R&D Officer -
Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
Director/Board Member -
Chief Tech/Sci/R&D Officer -
Voir l'expérience en détail de Ira N. Kalfus

Formation de Ira N. Kalfus

The Trustees of Columbia University in The City of New York Undergraduate Degree
Albert Einstein College of Medicine, Inc. Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Ira N. Kalfus

Relations

34

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
REDHILL BIOPHARMA LTD.

Health Technology

Entreprise privées8

Health Services

Health Services

Finance

Health Technology

Health Technology

Health Services

Finance

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Ira N. Kalfus